4//SEC Filing
Donnelly Richard G 4
Accession 0001079973-09-000086
CIK 0001167419other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 7:39 PM ET
Size
13.1 KB
Accession
0001079973-09-000086
Insider Transaction Report
Form 4
Donnelly Richard G
DirectorPresident & CEO
Transactions
- Award
Stock Options
2009-01-27+50,000→ 50,000 totalExercise: $1.33From: 2009-01-27Exp: 2019-01-27→ Common Stock (50,000 underlying)
Holdings
- 324,681
Common Stock
- 5,000(indirect: By IRA)
Common Stock
- 500,000
Stock Options
Exercise: $0.60From: 2005-02-01Exp: 2015-02-01→ Common Stock (500,000 underlying) - 50,000
Stock Options
Exercise: $6.63From: 2008-01-17Exp: 2018-01-17→ Common Stock (50,000 underlying) - 100,000
Stock Options
Exercise: $2.96From: 2007-01-24Exp: 2017-01-24→ Common Stock (100,000 underlying) - 75,000
Stock Options
Exercise: $1.40From: 2007-01-01Exp: 2016-07-14→ Common Stock (75,000 underlying)
Footnotes (5)
- [F1]Options vest over three years, at the rate of 33.3% at the end of year one, 66.7% at the end of year two, and 100% at the end of year three.
- [F2]Options were granted pursuant to Board approval on July 14, 2006 and were exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F3]Options and shares of common stock were granted pursuant to Board approval on January 24, 2007. The aggregate number of stock options granted was 100,000. One-third (33,333) of the options vest each year for three years following the date of grant. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F4]Options were granted pursuant to Board approval on January 17, 2008. The aggregate number of stock options granted was 50,000. One third (16,666) of the options vest each year for three years following the date of grant. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F5]Options were granted pursuant to Board approval on January 27, 2009. One third (16,666) of the options vest each year for three years following the date of grant. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).
Documents
Issuer
AspenBio Pharma, Inc.
CIK 0001167419
Entity typeother
Related Parties
1- filerCIK 0001316244
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 7:39 PM ET
- Size
- 13.1 KB